Merck forays into acquiring Viralytics augmenting Immuno-Oncology Pipeline
Merck and Viralytics claimed that the companies have ventured into a definitive agreement that enumerates Merck's acquisition of Viralytics emphasizing on oncolytic immunotherapy…
Read More...
Read More...